Recent Quotes

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately 29% of sales internationally, with the remainder 71% derived from the United States.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		0.570		0.690		0.1200
REV		349.810M		360.071M		10.261M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
IART	Integra Lifesciences	70.42	0.64	0.92%		6B

Integra Lifesciences Frequently Asked Questions

How do I buy Integra Lifesciences (IART) stock?

You can purchase shares of Integra Lifesciences (NASDAQ: IART) through any online brokerage.

View our list of the best stock brokerages.

Who are Integra Lifesciences's (IART) competitors?

Other companies in Integra Lifesciences’s space includes: Heska (NASDAQ:HSKA), Steris (NYSE:STE), Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST) and Inari Medical (NASDAQ:NARI).

What is the target price for Integra Lifesciences (IART) stock?

The latest price target for Integra Lifesciences (NASDAQ: IART) was reported by Credit Suisse on February 19, 2021. The analyst firm set a price target for 79.00 expecting IART to rise to within 12 months (a possible 12.18% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for Integra Lifesciences (IART)?

The stock price for Integra Lifesciences (NASDAQ: IART) is $70.42 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Integra Lifesciences (IART) pay a dividend?

There are no upcoming dividends for Integra Lifesciences.

When is Integra Lifesciences (NASDAQ:IART) reporting earnings?

Integra Lifesciences’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Integra Lifesciences (IART) going to split?

There is no upcoming split for Integra Lifesciences.

What sector and industry does Integra Lifesciences (IART) operate in?

Integra Lifesciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.